In­side CVS Care­mark’s move that broke Hu­mi­ra’s hold on the mar­ket

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.)

For the first time in April, biosim­i­lars start­ed to gain a larg­er share of the Hu­mi­ra mar­ket. Up un­til that point, the mar­ket felt unim­peach­able, with Ab­b­Vie’s Hu­mi­ra re­tain­ing 96% of the share by Feb­ru­ary. That changed when Hu­mi­ra came off the for­mu­la­ry of CVS Health’s phar­ma­cy ben­e­fit man­ag­er Care­mark.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER